期刊文献+

PTEN表达载体的构建及转染食管鳞癌细胞系EC9706

Construction of a Vector for Stable Expression of PTEN in Esophageal Squamous Cell Cancer Cell Line
下载PDF
导出
摘要 目的筛选稳定表达野生型PTEN基因的食管鳞癌细胞株EC9706。方法提取胎盘总RNA,设计引物,PCR扩增人野生型PTEN基因,经测序鉴定后,连接于pcDNA3.1(+)真核表达载体,构建pcDNA3.1-PTEN,用脂质体介导的方法将其转染EC9706。而后加抗生素G418筛选稳定表达株,用RT-PCR方法检测稳定表达株PTEN基因的mRNA水平,通过绘制生长曲线观察细胞生长情况。结果PCR产物的电泳结果显示,在1500bp左右有一明显亮带,测序结果与GenBank上PTEN序列完全一致;稳定表达PTEN基因的细胞株RT-PCR结果显示,PTEN的mRNA水平比对照细胞株相比明显升高;生长曲线结果显示,转染后的细胞生长速度明显减慢。结论所扩基因为野生型PTEN基因,所构建的载体为野生型PTEN基因真核表达载体,并筛选出PTEN基因稳定表达的食管鳞癌细胞株。 Objective To establish stable expression cell line transfected with eukaryotic expression vector of PTEN. Methods To clone the wild-type PTEN gene, total RNA was isolated from human placenta tissues. A cDNA of human PTEN was obtained by optimized RT-PCR and sequenced, and then the cDNA fragment was put into the eukaryotic expression plasmid pcDNA 3. 1 ( + ) to construct pcDNA 3. 1- PTEN. Cells of esophageal squamous cell cancer cell line EC9706 were transferred with pcDNA 3. 1- PTEN using lipofectamine. The stable expression cells were screened by G-418. RT-PCR and growth curve were done for identifying the screened cells. Results The cDNA fragment produced by RT-PCR had 100% homology with wild-type PTEN gene sequence on GenBank by BLAST. The mRNA level of PTEN increased notably in the cell line we screened, and the growth of the cell line was very solely compared with control cell lines. Conclusion Because of cells of esophageal squamous cell cancer which stably express PTEN were successfully screened, it is concluded that a PTEN eukaryotic vector for stable expression in esophageal squamous cell cancer cell line has been constructed.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第3期178-181,共4页 Cancer Research on Prevention and Treatment
基金 教育部"十五""211工程"重点学科建设项目(教重字[2002]第2号)
关键词 PTEN 食管鳞癌 MTOR 转染 PTEN Esophageal cancer mTOR Transfection
  • 相关文献

参考文献13

  • 1Kim JE,Chen J.Cytoplasmic-nuclear shuttling of FKBP-12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation[J].Proc Natl Acad Sci,USA,2000,97(26):14340-14345.
  • 2Gera JF,Mellinghoff IK,Shi Y,et al.AKT activity determines sensitivity to mammalian target of rapamycin(mTOR) inhibitors by regulating cyclin D1 and c-myc expression[J].J Biol Chem,2004,279(4):2737-2746.
  • 3Bjornsti MA,Houghton PJ.The TOR pathway:a target for cancer therapy[J].Nature Rev,2004,4(5):335-348.
  • 4Tolcher AW.Novel therapeutic molecular targets for prostate cancer:the mTORsignaling pathway and epidermal growth factor receptor[J].J Urol,2004,171(2 Pt 2):S41-S44.
  • 5Li J,Y en C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast and prostate cancer[J].Science,1997,275(5308):1943-1947.
  • 6Neshat MS,Mellinghoff IK,Tran C,et al.Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR[J].Proc Natl Acad Sci,USA,2001,98(18):10314-10319.
  • 7DeGraffenried LA,Fulcher L,Friedrichs WE,et al.Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3K kinase/Akt pathway[J].Ann Oncol,2004,15(10):1510-1516.
  • 8肖绍文,陈维平,谢小薰,罗国容,莫发荣,吴耀生.脑肿瘤中Pten/MMAC1/Tep1蛋白的表达[J].中国肿瘤,2000,9(7):332-333. 被引量:6
  • 9徐寿水,沈文律.转PTEN基因对人结肠癌细胞的抑制作用[J].肿瘤防治研究,2005,32(4):202-205. 被引量:4
  • 10Sulis ML,Parsons R.PTEN:from pathology to biology[J].Trends Cell Biol,2003,13(9):478-483.

二级参考文献19

  • 1Taniyama K, Goodison S, Ito R,et al. PTEN expression is maintained in sporadic colorectal tumours[J]. J Pathol, 2001,194(3):341-348.
  • 2Lilja JF, Wu D, Reynolds RK, et al. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells[J]. Anticancer Res, 2001,21(3B):1969-1974.
  • 3Li J, Yen C, Liaw D,et al. PTEN a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J]. Science, 1997,275:1943-1947.
  • 4Tashiro H, Blazes MS, Wu R, et al . Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies[J].Cancer Res, 1997,57(18):3935-3940.
  • 5Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15(4):356-362.
  • 6Fumari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells[J].Cancer Res, 1998,58(22): 5002-5008.
  • 7Saga Y, Mizukami H, Takei Y, et al. Suppression of cell migration in ovarian cancer cells mediated by PTEN overexpression. Int J Oncol. 2003,23(4): 1109-1113.
  • 8Nassif NT, Lobo GP, Wu X, et al. PTEN mutations are common in sporadic microsatellite stable colorectal cancer[J]. Oncogene, 2004,23(2):617-628.
  • 9Zhao H, Dupont J, Yakar S, et al. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells[J].Oncogene,2004,23(3): 786-794.
  • 10Li DM, Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells[J]. Proc Natl Acad Sci USA, 1998,95(26):15406-154111.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部